Estudo da atividade antileishmanial de um novo sal orgânico derivado de triazol em leishmania amazonensis
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Leishmaniasis is an infectious disease that is difficult to control and presents itself in
three clinical forms: cutaneous, mucocutaneous and visceral leishmaniasis, caused
by more than 20 species of parasites of the genus Leishmania spp., transmitted by
the insect vector, the sand fly. Current chemotherapy for leishmaniasis faces
significant limitations due to high toxicity, prolonged treatment regimens and
increased parasite resistance, highlighting the urgent need for new treatment
strategies. This study aimed to evaluate the in vitro activity of triazole derivatives
against promastigotes and amastigotes of L. amazonensis, as well as its cytotoxicity
in murine macrophages. In addition to investigate the mechanism of parasite killing.
antipromastigote activity and cytotoxicity in peritoneal macrophages were determined
by the colorimetric MTT method after 72 hours of treatment. The anti-amastigote
effect was evaluated in macrophages infected with L. amazonensis after 72 hours of
incubation, stained with Giemsa and counted by optical microscopy. The tests for
analysis of the mechanism of action were performed using different biochemical and
cellular indicators of cell death parameters, by fluorimetry and flow cytometry.
Additionally, the ultrastructure and morphology of promastigotes treated with TZDS
were analyzed by electron microscopy. The results found highlighted the importance
of triazole salts, since the neutral form did not show inhibition of parasite growth.
However, the triazole-derived salt demonstrated a promising selective index (SI =
34.28) and antileishmanial activity (IC50 = 0.13 μM and IC50 = 2.06 μM against
promastigote and amastigote forms, respectively), proving to be more active than
miltefosine, the standard drug. Regarding the TZDS mode of action, this compound
induced significant mitochondrial alterations in the parasite, characterized by an
increase in mitochondrial membrane potential (ΔΨm), elevated levels of total and
mitochondrial Reactive Oxygen Species (ROS), and accumulation of lipid bodies in
the cytoplasm. Treatment with triazole salt also produced several ultrastructural,
biochemical, and cellular alterations in the promastigotes, consistent with apoptosislike cell death, including cell shrinkage and reduction in length, as well as exposure
of phosphatidylserine in the outer leaflet of the plasma membrane and marked cell
cycle arrest, in addition to DNA fragmentation. Despite the positive MDC
(monodansylcadaverine) and the presence of membrane-bound vacuoles resembling
autophagosomal structures observed by TEM analysis, autophagy is not a
predominant process, with severe mitochondrial damage emerging as the primary
event leading to parasite death. These findings demonstrate the promising
antileishmanial potential of the triazole-derived salt, with its effect on multiple targets
in L. amazonensis cells. Furthermore, the association of the active compound with
miltefosine showed an additive effect in the treatment of macrophages infected by L.
amazonensis. Overall, these results highlight the therapeutic potential of the
evaluated salt and support further studies to evaluate its in vivo efficacy in a murine
model of cutaneous leishmaniasis.
Description
Keywords
Leishmaniose , Tratamento , Triazol , Sal orgânico , Apoptose , Leishmaniasis , Treatment , Triazole , Organic salt , Apoptosis
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

